Bioorganic and Medicinal Chemistry Letters p. 1791 - 1796 (1998)
Update date:2022-09-26
Topics:
Chambers
Antognoli
Cheng
Marfat
Pillar
Shirley
Watson
By addressing the issues of potency and metabolism in 3, a new series of LTD4 antagonists represented by (+)-26 was developed which is equipotent to clinical LTD4 antagonists Zafirlukast (1) and Pranlukast (2).
View MoreHangzhou Mole's Science & Technology Co.,Ltd.(expird)
Contact:+86-571-56880228
Address:15F Guodu development Building, NO.182 Zhaohui Road
Shanghai Haoyuan Chemexpress Co., Ltd.
website:https://www.chemexpress.com/
Contact:86-21-58950125
Address:No.3 Building, No.1999, Zhangheng Road, ZhangjiangHighTech Park, Shanghai, P.R.China,201203
Jiangxi Province Bethel Pharmaceutical Co., Ltd.
Contact:+86-795-259 3456 ,+86-15957688008 13566650571
Address:Huangjindui Chemical Park, Shanggao County ,Yichun city,Jiangxi Province
Daqing E-shine Chemical Co.,LTD
Contact:0086-024-31285112
Address:Hongweiyuan area, Ranghulu district
Synchem Pharma Co.,Ltd(expird)
Contact:+0086-21-61984905-1
Address:Building 60,Zimian Park, LongYang industrial Area, 1515Nong,Yuandong Road Fengxian District, Shanghai ,China
Doi:10.1016/S0040-4039(97)01002-2
(1997)Doi:10.1039/a807718e
(1999)Doi:10.1002/hlca.19970800424
(1997)Doi:10.1021/acs.organomet.7b00603
(2018)Doi:10.1016/S0040-4020(97)00526-7
(1997)Doi:10.1021/jo970548x
(1997)